Assessing the Impact of Morphine on Adverse Outcomes in ACS Patients Treated with P2Y12 Inhibitors: Insights from Multiple Real-World Evidence.

Chenxi OuyangChangjiang MengFei LiShanshan NieLiying GongYu CaoHong YuanZe-Ying Feng

Published in: Drug design, development and therapy (2024)

The administration of morphine in patients treated with P2Y12 receptor inhibitors should be carefully evaluated. PCT may serve as a potential warning indicator for morphine-related renal injury.

Keyphrases

acute coronary syndrome
binding protein